Metraipolis › archive › dc_60370fbf6702
Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41804189
- DOI
- 10.1111/dom.70625
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T00:24:15.210Z
- SHA-256 of the archived text
2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2- Stable URL of this page
https://metraipolis.com/documento/dc_60370fbf6702
How to cite
Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189 — Europe PMC (en), https://europepmc.org/article/MED/41804189 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60370fbf6702 (Metraipolis archive dc_60370fbf6702, sha256 2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2)
BibTeX
@misc{dc60370fbf6702,
title = {Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41804189},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60370fbf6702; sha256 2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41804189. Agents can read the archived copy with the MCP tool read_document.